Cellino

Cellino Chief Operating Officer Dr. Abhijit Kulkarni Inducted Into AIMBE’s 2023 College of Fellows

Retrieved on: 
Tuesday, March 28, 2023
Biotechnology, Health, Neurology, Stem Cells, Nobel Prize, Medicine, Education, Innovation, Research, Biology, College of Fellows of the American Theatre, Engineering, Pain management, ARD International Music Competition, American Institute, American Institute for Medical and Biological Engineering, AIMBE, Science, College, Cellino

Cellino Biotech, Inc. , an autologous cell therapy technology platform company, today announced that Chief Operating Officer Abhijit Kulkarni, Ph.D., was inducted to The American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.

Key Points: 
  • Cellino Biotech, Inc. , an autologous cell therapy technology platform company, today announced that Chief Operating Officer Abhijit Kulkarni, Ph.D., was inducted to The American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.
  • Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer.
  • Dr. Kulkarni was inducted along with 140 colleagues who make up the AIMBE College of Fellows Class of 2023.
  • “I am honored to be inducted into the College of Fellows alongside such an esteemed class of engineers,” said Dr. Kulkarni, COO at Cellino.

Cellino Announces Appointment of Abhijit Kulkarni, Ph.D. as Chief Operating Officer and Paulette Dillon as Chief Business Officer

Retrieved on: 
Monday, June 27, 2022
Technology, Other Technology, Health Technology, Stem Cells, Software, Biotechnology, Health, Pharmaceutical, Artificial Intelligence, Patient, Biotechnology, Technology, Senior, Therapy, Engineering, BCEL, Bionics, Development, Abhi, Syntex, Boston, Physics, Corporate development, SVP, Hoffmann-La Roche, MIT, Bose Corporation, Doctor of Philosophy, Neuromodulation, Celera Corporation, Quest Diagnostics, NASDAQ, Biomedical engineering, Amgen, Twitter, Paulette, Global, Pfizer, Management, Pharmaceutical industry, Anacor, Medtronic, Electronics, Exelixis, Research, Cellino

Cellino Biotech, Inc. , an autonomous cell therapy technology platform company, today announced the expansion of its executive leadership team with the appointments of Abhijit (Abhi) Kulkarni, Ph.D. as Chief Operating Officer and Paulette Dillon as Senior Vice President (SVP) and Chief Business Officer.

Key Points: 
  • Cellino Biotech, Inc. , an autonomous cell therapy technology platform company, today announced the expansion of its executive leadership team with the appointments of Abhijit (Abhi) Kulkarni, Ph.D. as Chief Operating Officer and Paulette Dillon as Senior Vice President (SVP) and Chief Business Officer.
  • We are delighted to welcome Abhi and Paulette, who bring invaluable expertise in advanced technology development and business to Cellino, said Nabiha Saklayen, Ph.D., Chief Executive Officer & Co-Founder, Cellino.
  • Abhi brings over 25 years of experience working on innovative solutions spanning the disciplines of neuroscience, engineering, and physics.
  • Prior to joining Cellino, she was Senior Vice President of Corporate Development and Co-Founder of Atreca, Inc., (NASDAQ: BCEL) a public biopharmaceutical antibody-based company.

Bayer Set to Drive Breakthrough Innovations in the Life Sciences

Retrieved on: 
Friday, April 1, 2022
Other Health, Research, Pharmaceutical, Other Natural Resources, Agriculture, Natural Resources, Genetics, Science, Biotechnology, Stem Cells, Other Science, Health, Carbon, Pulmonary fibrosis, Disease, Risk, Therapy, Trust, Group, Primary health care, Climate change, Safety and Health in Agriculture Convention, 2001, Growth, Board, Ownership, Agricultural science, Ukko, Cellino, Artificial intelligence, Industry, Biology, Farmer, Seed, Chief executive officer, Cell, Acquisition, Medication, RNA interference, Ageing, Glycogen storage disease type II, Crop protection, Chemistry, List of life sciences, Drug discovery, Solution, Informatics for Consumer Health, Heart, Development, Richard Barker (life sciences and healthcare leader), Weather, Bluerock Creek, Food, Food security, Patient, Fine chemical, Agriculture, Pharmaceutical industry, Health, Pharma, Finance Secretary (India), Bayer, Agriculture

Today, Bayer held its first ever Breakthrough Innovation Forum, focusing on longer-term opportunities for health and agriculture leveraging emerging technologies.

Key Points: 
  • Today, Bayer held its first ever Breakthrough Innovation Forum, focusing on longer-term opportunities for health and agriculture leveraging emerging technologies.
  • The event followed Bayers recent short- and mid-term pipeline updates for its Pharma and Crop Science Divisions and shared further insights on Bayers ongoing progress to drive long-term breakthrough innovations in the Life Sciences.
  • We stand at the dawn of a new age of innovation in the Life Sciences, said Werner Baumann, Chairman of the Board of Management of Bayer AG.
  • The event also provided tangible examples of Bayers ongoing work to change the paradigms in Life Sciences.

Leaps by Bayer Leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing

Retrieved on: 
Tuesday, January 25, 2022
Stem Cells, Software, Biotechnology, Pharmaceutical, Hardware, Health, Technology, Genetics, IPSC, Felicis Ventures, Group, Artificial intelligence, National, Lead, Khosla Ventures, Patient, Doctor of Philosophy, Agriculture, Deep learning, Regenerative medicine, Investment, Trust, Twitter, Bayer, Multimedia, Growth, CEO, Nature, Clinical trial, Solution, NIH, Ageing, GMP, Machine learning, Biotechnology, MD, Health, Pharmaceutical industry, Engine, Cellino, Bayer and Leaps by Bayer, Cellino, BAYER AND LEAPS BY BAYER, CELLINO

Cellino Biotech, Inc. , an autonomous cell therapy manufacturing company, today announced the completion of a Series A financing of $80 million, led by the impact investment arm of Bayer AG Leaps by Bayer 8VC, and Humboldt Fund.

Key Points: 
  • Cellino Biotech, Inc. , an autonomous cell therapy manufacturing company, today announced the completion of a Series A financing of $80 million, led by the impact investment arm of Bayer AG Leaps by Bayer 8VC, and Humboldt Fund.
  • Currently, large scale production of stem cell therapies is challenging due to extensive manual handling, high variability, and expensive manufacturing costs.
  • Cellinos next-generation manufacturing platform combines artificial intelligence (AI) and laser technology to automate cell therapy manufacturing to reduce expenditures and overcome scaling limitations.
  • Investing in Cellino represents a unique opportunity for Leaps by Bayer to continue to fund the development of next-generation therapies.

Cellino Appoints Industry Pioneer Robert J. Palay to the Board

Retrieved on: 
Tuesday, August 3, 2021
Technology, Surgery, Medical devices, General Health, Science, Genetics, Biotechnology, Health, Other Science, Research, Other Technology, Software, Other Health, Hardware, Pharmaceutical, Stem cells, Oncology, Branches of biology, Biology, Life sciences, Induced stem cells, Stem cells, Biotechnology, Cloning, Developmental biology, Induced pluripotent stem cell, Cellino, IPSC

Cellino , a personalized regenerative medicine company developing an AI-guided laser editing platform for autologous cell-based therapies, today announced the appointment of industry pioneer Robert J. Palay, J.D., M.B.A., to the Cellino Board of Directors.

Key Points: 
  • Cellino , a personalized regenerative medicine company developing an AI-guided laser editing platform for autologous cell-based therapies, today announced the appointment of industry pioneer Robert J. Palay, J.D., M.B.A., to the Cellino Board of Directors.
  • View the full release here: https://www.businesswire.com/news/home/20210803005032/en/
    Mr. Palay is one of the pioneers of the induced pluripotent stem cell (iPSC) industry.
  • "We are pleased to welcome Robert to the Cellino Board," said Nabiha Saklayen, Ph.D, CEO & Co-Founder, Cellino.
  • "I am thrilled to join the Cellino Board," said Robert J. Palay.

Cellino CEO Dr. Nabiha Saklayen Awarded Inaugural Tory Burch Fellowship at the Innovative Genomics Institute

Retrieved on: 
Thursday, May 20, 2021
Health, Technology, Other Technology, Other Science, General Health, Research, Science, Awards, Howard Hughes Medical Investigators, Tory Burch, Igi, Jennifer Doudna, Fashion, Burch, Science and technology awards, the Tory Burch Foundation, the Innovative Genomics Institute, Cellino, THE TORY BURCH FOUNDATION, THE INNOVATIVE GENOMICS INSTITUTE, CELLINO

b'Cellino , a personalized regenerative medicine company developing an AI-guided laser editing platform for autologous cell-based therapies, today announced that its CEO Dr. Nabiha Saklayen has been awarded the first Tory Burch Fellowship at the International Genomics Institute (IGI).\nThis press release features multimedia.

Key Points: 
  • b'Cellino , a personalized regenerative medicine company developing an AI-guided laser editing platform for autologous cell-based therapies, today announced that its CEO Dr. Nabiha Saklayen has been awarded the first Tory Burch Fellowship at the International Genomics Institute (IGI).\nThis press release features multimedia.
  • They face the same barriers that women entrepreneurs typically face, including limiting stereotypes and a lack of access to capital, education and networks.
  • This Fellowship program is the Tory Burch Foundation\xe2\x80\x99s first contribution to the vital issue of women in STEM and we could not be more thrilled to be partnering with brilliant, trailblazing Jennifer Doudna and the Innovative Genomics Institute,\xe2\x80\x9d said Tory Burch, CEO at Tory Burch.\n"Part of our mission at the Innovative Genomics Institute is to be the bridge from research to real-world impact,\xe2\x80\x9d said Dr. Doudna.
  • We are delighted to partner with the Tory Burch Foundation and welcome Dr. Saklayen as our first fellow.\xe2\x80\x9d\n\xe2\x80\x9cI am honored to receive the first Tory Burch Fellowship at the IGI and have Nobel Prize Laureate Dr. Jennifer Doudna and leading designer and entrepreneur Tory Burch as mentors,\xe2\x80\x9d said Nabiha Saklayen, Ph.D., CEO and Co-Founder at Cellino.

Win up to $25,000 for your favorite WNY Nonprofit!

Retrieved on: 
Sunday, March 1, 2020
Bathrooms, Building engineering, Plumbing, Cellino

BUFFALO, N.Y., March 1, 2020 /PRNewswire-PRWeb/ -- Cellino Plumbing Heating & Cooling will be adding a new truck to their fleet this spring, inspired by a Western New York nonprofit organization!

Key Points: 
  • BUFFALO, N.Y., March 1, 2020 /PRNewswire-PRWeb/ -- Cellino Plumbing Heating & Cooling will be adding a new truck to their fleet this spring, inspired by a Western New York nonprofit organization!
  • This custom wrapped truck will join the Cellino Plumbing fleet to help spread awareness about that organization.
  • Cellino Plumbing will additionally lend support to by donating 5% of that truck's revenue for 12 months.. could be up to $25,000!